Unsorted
The battle over pharmaceutical patents and the Indian drug market
In the late 1990s, Novartis manufactured and patented imatinib (with the brand name Gleevec), a drug that prolongs life in patients with chronic myelogenous leukemia (CML). Since its release, imatinib has offered hope for patients suffering from (CML);…
March 15, 2012Unsorted5 min read